Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Altman

Showing results (111-120 of 365) with videos related to

Pageof 37
Sort By:
Blood|October 3, 2009
How I treat acute promyelocytic leukemiaMartin S Tallman, Jessica K Altman
The Journal of the Kansas Medical Society|February 1, 1978
Retarded children. An update for physicians on program alternativesK Altman, S Haavik, C Woelk
Current Hematologic Malignancy Reports|March 20, 2014
Contemporary treatment of APLElizabeth H Cull, Jessica K Altman
Hematology. American Society of Hematology. Education Program|December 17, 2008
Curative strategies in acute promyelocytic leukemiaMartin S Tallman, Jessica K Altman
The New York Times on the Web|June 19, 2003
An ethical dilemma with few precedentsSheryl Gay Stolberg, Lawrence K Altman
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|May 21, 2019
Harnessing big data for identifying atrial fibrillationRobert K Altman, Jonathan S Steinberg
Leukemia & Lymphoma|April 18, 2009
Prospects for mTOR targeting in adult T cell leukemiaJessica K Altman, Leonidas C Platanias
Leukemia & Lymphoma|April 18, 2012
NME1 and NME2 as markers for myeloid leukemiasJessica K Altman, Leonidas C Platanias
Current Opinion in Hematology|February 28, 2008
Exploiting the mammalian target of rapamycin pathway in hematologic malignanciesJessica K Altman, Leonidas C Platanias
Current Opinion in Hematology|January 31, 2016
Optimal treatment strategies for high-risk acute promyelocytic leukemiaKelly J Norsworthy, Jessica K Altman
Pageof 37

Showing results (111-120 of 365) with videos related to

Sort By:
Pageof 37
Blood|October 3, 2009
How I treat acute promyelocytic leukemiaMartin S Tallman, Jessica K Altman
The Journal of the Kansas Medical Society|February 1, 1978
Retarded children. An update for physicians on program alternativesK Altman, S Haavik, C Woelk
Current Hematologic Malignancy Reports|March 20, 2014
Contemporary treatment of APLElizabeth H Cull, Jessica K Altman
Hematology. American Society of Hematology. Education Program|December 17, 2008
Curative strategies in acute promyelocytic leukemiaMartin S Tallman, Jessica K Altman
The New York Times on the Web|June 19, 2003
An ethical dilemma with few precedentsSheryl Gay Stolberg, Lawrence K Altman
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|May 21, 2019
Harnessing big data for identifying atrial fibrillationRobert K Altman, Jonathan S Steinberg
Leukemia & Lymphoma|April 18, 2009
Prospects for mTOR targeting in adult T cell leukemiaJessica K Altman, Leonidas C Platanias
Leukemia & Lymphoma|April 18, 2012
NME1 and NME2 as markers for myeloid leukemiasJessica K Altman, Leonidas C Platanias
Current Opinion in Hematology|February 28, 2008
Exploiting the mammalian target of rapamycin pathway in hematologic malignanciesJessica K Altman, Leonidas C Platanias
Current Opinion in Hematology|January 31, 2016
Optimal treatment strategies for high-risk acute promyelocytic leukemiaKelly J Norsworthy, Jessica K Altman
Pageof 37